Tailored therapy aims to cut side effects for throat cancer patients
NCT ID NCT05894083
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving patients with a specific type of throat cancer (p16+ oropharyngeal cancer) a personalized, less intense treatment can keep cancer from coming back while reducing side effects. About 150 adults with early-stage disease will either have surgery followed by observation or limited radiation, or receive customized chemoradiation. The main goal is to see how many patients remain cancer-free in the throat area after two years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan Rogel Cancer Center
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mouth rinse could ease painful radiation side effects for head and neck cancer patients
- New drug combo targets HPV-Driven cancers in phase II trial
- New drug aims to spare cancer patients from debilitating mouth sores
- New lozenge aims to ease radiation mouth sores for hours
- New sedative could speed recovery for ventilator patients
- Can MRI measurements be trusted for head and neck cancer?